NO166039C - Analogifremgangsmaate for fremstilling av steroido(3,2-c)pyrazoler med antiandrogen virkning. - Google Patents

Analogifremgangsmaate for fremstilling av steroido(3,2-c)pyrazoler med antiandrogen virkning.

Info

Publication number
NO166039C
NO166039C NO862506A NO862506A NO166039C NO 166039 C NO166039 C NO 166039C NO 862506 A NO862506 A NO 862506A NO 862506 A NO862506 A NO 862506A NO 166039 C NO166039 C NO 166039C
Authority
NO
Norway
Prior art keywords
steroido
pyrazoles
preparation
drug effect
analogue procedure
Prior art date
Application number
NO862506A
Other languages
English (en)
Other versions
NO862506D0 (no
NO862506L (no
NO166039B (no
Inventor
Robert George Christiansen
Malcolm Rice Bell
John Lawrence Herrmann Jr
Chester Joseph Opalka Jr
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of NO862506D0 publication Critical patent/NO862506D0/no
Publication of NO862506L publication Critical patent/NO862506L/no
Publication of NO166039B publication Critical patent/NO166039B/no
Publication of NO166039C publication Critical patent/NO166039C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0047—Nitrogen only at position 2(3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
NO862506A 1985-06-24 1986-06-23 Analogifremgangsmaate for fremstilling av steroido(3,2-c)pyrazoler med antiandrogen virkning. NO166039C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74837885A 1985-06-24 1985-06-24
US06/849,582 US4684636A (en) 1985-06-24 1986-04-08 Antiandrogenic sulfonylsteroidopyrazoles and processes for preparation method of use and compositions thereof

Publications (4)

Publication Number Publication Date
NO862506D0 NO862506D0 (no) 1986-06-23
NO862506L NO862506L (no) 1986-12-29
NO166039B NO166039B (no) 1991-02-11
NO166039C true NO166039C (no) 1991-05-29

Family

ID=27114932

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862506A NO166039C (no) 1985-06-24 1986-06-23 Analogifremgangsmaate for fremstilling av steroido(3,2-c)pyrazoler med antiandrogen virkning.

Country Status (19)

Country Link
US (1) US4684636A (no)
EP (1) EP0207375B1 (no)
KR (1) KR910002228B1 (no)
AR (2) AR242798A1 (no)
AT (1) ATE45164T1 (no)
AU (1) AU581767B2 (no)
CA (1) CA1255294A (no)
DE (1) DE3664775D1 (no)
DK (1) DK293786A (no)
ES (2) ES8800690A1 (no)
FI (1) FI83425C (no)
GR (1) GR861613B (no)
IL (1) IL79046A0 (no)
MY (1) MY101921A (no)
NO (1) NO166039C (no)
NZ (1) NZ216438A (no)
PH (1) PH22087A (no)
PT (1) PT82837B (no)
ZA (1) ZA864199B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134135A (en) * 1990-06-21 1992-07-28 Sterling Drug Inc. Antiandrogenic sulfonylsteroidooxazoles
US5100882A (en) * 1990-06-21 1992-03-31 Sterling Drug Inc. Antiandrogenic sulfonylsteroidofurans
US5053405A (en) * 1990-06-21 1991-10-01 Sterling Drug Inc. Antiandrogenic sulfonylsteroidothiazoles
DE4021433A1 (de) * 1990-07-04 1992-01-09 Schering Ag Antiandrogene mit steroid(3,2-c)pyrazol-struktur
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions
US5175155A (en) * 1991-10-07 1992-12-29 Sterling Winthrop Inc. Win 49596-finasteride method of use and compositions
DE4227465A1 (de) * 1992-08-17 1994-02-24 Schering Ag Antiandrogene Steroide mit aneliertem Fünfring
AU2256702A (en) * 2000-12-01 2002-06-11 Kyowa Hakko Kogyo Kk Composition improved in solubility or oral absorbability

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL100550C (no) * 1959-02-16
US2945852A (en) * 1959-05-20 1960-07-19 Searle & Co 17-oxygenated 9alpha-substituted androstano [3, 2-c] pyrazoles and derivatives
US4356175A (en) * 1978-10-10 1982-10-26 The Upjohn Company 17β-Hydroxy-17α-methyl-5α-androstano-[3,2-c]pyrazole 17-methyl ether
US4297350A (en) * 1978-10-10 1981-10-27 The Upjohn Company Male contraceptive steroids and methods of use

Also Published As

Publication number Publication date
KR870010074A (ko) 1987-11-30
DK293786D0 (da) 1986-06-23
NO862506D0 (no) 1986-06-23
ATE45164T1 (de) 1989-08-15
FI862637A0 (fi) 1986-06-19
FI83425C (fi) 1991-07-10
ES8800690A1 (es) 1987-11-16
EP0207375A1 (en) 1987-01-07
GR861613B (en) 1986-10-30
AR242798A1 (es) 1993-05-31
AU5896586A (en) 1987-01-08
CA1255294A (en) 1989-06-06
NO862506L (no) 1986-12-29
KR910002228B1 (ko) 1991-04-08
ES556422A0 (es) 1987-11-16
ES8801929A1 (es) 1988-03-01
PT82837A (en) 1986-07-01
FI83425B (fi) 1991-03-28
AU581767B2 (en) 1989-03-02
FI862637A (fi) 1986-12-25
NO166039B (no) 1991-02-11
MY101921A (en) 1992-02-15
ZA864199B (en) 1987-01-28
NZ216438A (en) 1989-01-06
PT82837B (pt) 1988-04-21
AR243201A1 (es) 1993-07-30
EP0207375B1 (en) 1989-08-02
PH22087A (en) 1988-05-20
IL79046A0 (en) 1986-09-30
DK293786A (da) 1986-12-25
DE3664775D1 (en) 1989-09-07
ES557699A0 (es) 1988-03-01
US4684636A (en) 1987-08-04

Similar Documents

Publication Publication Date Title
NO862651D0 (no) Fremgangsmaate for fremstilling av isoksazol- og furanderivater.
NO170540C (no) En analogifremgangsmaate for fremstilling av 1-hydroksy-2-pyridoner
ES531285A0 (es) Procedimiento de preparacion de derivados de 1,3-dihidro-6-metil-7-hidroxi-furo-(3,4-c)-piridina
NO862861D0 (no) Fremgangsmaate for fremstilling av distamycinderivater.
NO863251D0 (no) Fremgangsmaate for fremstilling av sphingosinderivater.
NO166039C (no) Analogifremgangsmaate for fremstilling av steroido(3,2-c)pyrazoler med antiandrogen virkning.
NO164030C (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO860429L (no) Fremgangsmaate for fremstilling av imidazolyl-indol-derivater.
NO167980C (no) Analogifremgangsmaate for fremstilling av tienoimidazol-derivater.
NO169441C (no) Fremgangsmaate til fremstilling av 7-oksomitosanderivater
NO163010C (no) Fremgangsmaate for fremstilling av n-sulfamyl-3-(2-guanidino-thiazolo-4-yl-methylthio)-propionamid.
NO860273L (no) Fremgangsmaate for fremstilling av 4,4-dialkyl-2-azetidinoner.
NO157654C (no) Fremgangsmaate for fremstilling av 5,6,7,7a-tetrahydro-4h-thieno-(3,2-c)-pyridin-on-derivater.
NO863769D0 (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid.
NO864087D0 (no) Fremgangsmaate for fremstilling av aroylthiazoloner.
NO872199D0 (no) Analogifremgangsmaate for fremstilling av alkoxyalkyl- og alkylmercaptoalkylsubstituerte benzofuroisokinoliner.
NO862493D0 (no) Fremgangsmaate for fremstilling av 2-halonicergolinderivater.
NO863044D0 (no) Fremgangsmaate for fremstilling av 5,6-dialkoksyantranilsyrer.
NO864305D0 (no) Fremgangsmaate for fremstilling av 5-nafthyl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
NO861178L (no) Fremgangsmaate for fremstilling av 1,8-nafthyridinoner.
ES537426A0 (es) Procedimiento de preparacion de derivados de 1, 2-dihidropiridinas
NO922253D0 (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater
NO172488C (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater
ES539138A0 (es) Procedimiento de preparacion de derivados de la 1,4-dihidroquinoleina
NO900651L (no) Fremgangsmaate for fremstilling av 2-benzyl-1-nafthol.